CXCR4 is known to be upregulated in breast tumors; neutralizing the interaction of CXCL12 with CXCR4 significantly reduces breast cancer cell metastases in vivo [42], as does the repression of CCL5 that has anti-migratory effects [43]. This evidence concerns the gene CCL5 and breast cancer.